Quantcast

Latest Karmanos Cancer Institute Stories

2011-04-30 11:00:00

DETROIT, April 30, 2011 /PRNewswire/ -- The General Motors Foundation awarded the Karmanos Cancer Institute a $50,000 grant Saturday evening for research to help the nationally renowned Detroit-based center in its work toward curing and treating cancer. The grant was announced at the Karmanos' Annual Fundraising dinner by General Motors Co. Chairman and CEO Dan Akerson and his wife Karin, co-chairs for the event. In addition to the foundation's grant, GM supported the Institute's...

2011-02-08 11:04:00

DETROIT, Feb. 8, 2011 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute is honored to announce that Dan Akerson, chairman and chief executive officer of General Motors Company, and his wife, Karin, will serve as chairs of this year's Annual Dinner gala. The 29th Annual Dinner is one of Detroit's leading charitable events that raises critical funds to support groundbreaking cancer research, exceptional patient care and education at Karmanos. (Logo:...

2011-02-01 10:48:00

DETROIT, Feb. 1, 2011 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Center has named David Gorski, M.D., Ph.D., leader of the Breast Multidisciplinary Team (MDT), effective Tuesday, Feb. 1. The announcement was made by Gerold Bepler, M.D., Ph.D., president and CEO of Karmanos Cancer Institute. (Logo: http://photos.prnewswire.com/prnh/20071106/KARMANOSLOGO) As Breast MDT leader, Dr. Gorski is responsible for coordinating interdisciplinary collaboration among Karmanos' cancer...

2010-11-12 14:36:00

$4 Million National Cancer Institute Grant Spurs Southeast Michigan Partners Against Cancer DETROIT, Nov. 12, 2010 /PRNewswire-USNewswire/ -- Three institutions dedicated to health, innovative science and quality cancer care announced today the creation of the Southeast Michigan Partners Against Cancer (SEMPAC) to help close the gap on racial disparities related to cancer care in southeast Michigan. SEMPAC is made possible by a more than $4 million, five-year grant from the National...

2010-10-28 13:56:00

Abstract # 3179 SAN DIEGO, Oct. 28 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and...

2010-10-18 15:48:00

DETROIT, Oct. 18 /PRNewswire-USNewswire/ -- Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer - triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute. (Logo:...

2010-09-23 11:43:00

2010 Komen Detroit Race for the Cure® Accomplishments DETROIT, Sept. 23 /PRNewswire-USNewswire/ -- Susan G. Komen Detroit Race for the Cure® announced that it has awarded more than $1.5 million to local breast cancer education, screening and treatment programs as a result of $2.3 million raised in the 2010 Komen Detroit Race for the Cure®, locally presented by the Barbara Ann Karmanos Cancer Institute. The announcement was made...

2010-09-15 15:06:00

DETROIT, Sept. 15 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Center in Detroit was recently selected to be one of 50 sites in the United States to offer the new U.S. Food and Drug Administration (FDA)-approved drug PROVENGE® (sipuleucel-T) to treat patients with advanced metastatic prostate cancer. (Logo: http://photos.prnewswire.com/prnh/20071106/KARMANOSLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) PROVENGE, manufactured by...

2010-06-05 14:00:00

CHICAGO, June 5 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented preliminary data that shows nitrogen-containing bisphosphonates, therapeutic agents used to promote bone health and inhibit resorption, may cause a slightly poorer survival rate in post-menopausal women with early stage breast cancer who take them for their anti-osteoporosis properties. The findings were announced today at the 2010 American Society of Clinical Oncology...

2010-06-03 08:56:00

Student-Led Venture Fund Participates in $8 Million Series A Round of Financing led by Co-Investor Arboretum Ventures ANN ARBOR, Mich., June 3 /PRNewswire/ -- The Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, today announced participation in an $8 million series A round of financing for Delphinus Medical Technologies, Inc. Detroit-based Delphinus Medical...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related